A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ES
Long Form : excessive sleepiness
No. Year Title Co-occurring Abbreviation
2019 Comorbidities, Health-Related Quality of Life, and Work Productivity Among People With Obstructive Sleep Apnea With Excessive Sleepiness: Findings From the 2016 US National Health and Wellness Survey. ESS, HRQoL, OSA
2019 Factors related to excessive sleepiness in patients with Parkinson's disease. PD
2019 Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study. ESS, LS, MWT, PGIC
2018 Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor. DA, NE, OSA
2015 The effect of physician continuing medical education on patient-reported outcomes for identifying and optimally managing obstructive sleep apnea. CME, OSA, TTM
2013 Excessive sleepiness prevalence in public transportation drivers of a developing country. CI, ESQ
2012 Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. ---
2011 Brazilian air traffic controllers exhibit excessive sleepiness. AIS, ATCo, mins, SL
2010 Armodafinil in the treatment of excessive sleepiness. OSA, SWD
10  2010 Armodafinil in the treatment of sleep/wake disorders. ---
11  2010 Excessive sleepiness: under-recognized and essential marker for sleep/wake disorder management. SWG
12  2010 Impaired health status, daily functioning, and work productivity in adults with excessive sleepiness. ---
13  2010 Managing the patient with shift-work disorder. SWD
14  2010 Recognition of shift-work disorder in primary care. SWD
15  2010 The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study. BFI, CGIC, ESS, OSA, SWD
16  2009 Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies. AUC
17  2009 Obstructive sleep apnea (OSA) and excessive sleepiness associated with OSA: recognition in the primary care setting. CPAP, CV, OSA
18  2009 Optimal treatment of obstructive sleep apnea and excessive sleepiness. CPAP, OSA
19  2009 Recognizing and managing obstructive sleep apnea in primary care. OSA
20  2008 Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. MWT, nCPAP, OSA
21  2008 The burden of obstructive sleep apnea and associated excessive sleepiness. OSA, PCP
22  2007 Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study. CPAP, ESS, FOSQ, nCPAP, OSA/HS, SF-36
23  2006 Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. AEs, BFI, CGIC, ESS, MWT, nCPAP, OSA/HS
24  2006 Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. MWT, PVT
25  2005 Modafinil: new indications for wake promotion. OSAHS, SWSD
26  2005 [Excessive daytime sleepiness]. ---